In the second part, the discussion turns to emerging DED therapies that target tear function and ocular surface homeostasis.

The United Laboratories International Holdings ( ($HK:3933) ) has issued an announcement. The United Laboratories International Holdings Limited ...

Formosa and Rxilient have an exclusive licensing agreement for APP13007 commercialization, including regulatory and sales ...

For people with age-related blurry vision, once-a-day prescription eye drops offer a quick fix that lasts for up to 10 hours. Vizz (aceclidine ophthalmic solution) eye drops received FDA approval for ...

The FDA approved pilocarpine hydrochloride ophthalmic solution (Qlosi) for adults with presbyopia, according to a statement from Orasis Pharmaceuticals. The approval allows for daily or as-needed use, ...

What is it, and why does it matter? Vizz (aceclidine ophthalmic solution) is a new prescription eye drop approved to treat presbyopia, a common condition that makes it harder to see things up close as ...

The FDA approved aceclidine 1.44% ophthalmic solution (Vizz) for adults with presbyopia, or age-related blurred near vision, maker Lenz Therapeutics announced on Thursday. It marks the first ...

A South Florida drug maker recalled 199,584 bottles of three ophthalmic solutions because of a “lack of assurance on sterility.” That’s from FDA alert that the recalls from Apotex’s Weston facility ...

Opus Genetics, Inc. announced positive topline results from its VEGA-3 Phase 3 clinical trial evaluating Phentolamine Ophthalmic Solution 0.75% for treating presbyopia, achieving its primary and key ...